相关实验视频

Updated: May 25, 2025

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

免疫抑制治疗和与B型肝炎疫苗接种无反应相关的危险因素:一个队列研究

Raquel Padilla-Matas¹, Victoria Salguero-Cano^1,2, Eva Soler-Iborte¹

¹Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain.

|February 26, 2025

概括

免疫抑制药物治疗,老年和吸烟增加了对乙型肝炎疫苗接种无反应的风险. 这凸显了在高风险患者群体中需要优化疫苗接种策略的需要.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
公共卫生公共卫生

背景情况:

乙型肝炎疫苗接种对于预防感染至关重要.
免疫抑制疗法可能会损害疫苗的反应.
识别对乙型肝炎疫苗接种无反应者对于公共卫生至关重要.

研究的目的:

在接受免疫抑制治疗的患者中评估乙型肝炎疫苗接种的血清反应.
确定与B型肝炎疫苗接种无反应相关的因素.

主要方法:

未来的队列研究设计.
包括接受免疫抑制疗法的患者.
两变量和多变量逻辑双项回归分析以确定非响应因子.

主要成果:

免疫抑制治疗显著增加了不反应的风险 (RR = 2.49).
细胞毒性疗法,抗CD20和抗JAK治疗与不响应有关.
老年,吸烟和特定的疫苗方案也与不响应相关.

结论:

接受免疫抑制治疗的患者,老年人和吸烟者面临不对乙型肝炎疫苗接种反应的更高风险.
这些发现支持针对风群体量身定制的乙型肝炎疫苗接种方案的必要性.
即使在增强剂后,也观察到持续的不响应.

关键词:

在安达卢西亚,安达卢西亚.生物学的生物学.年长的老人老年人老年人.一个单克隆抗体.吸烟是为了吸烟.

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Vaccinations

Vaccinations

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...